TCT-509 Eighteen-month results of high-risk patients treated with ultrathin-strut biodegradable-polymer Orsiro DES. The Bioflow-III Satellite Italy Subgroups analysis.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）
Abstract
Thin-strut biodegradable-polymer DES (Orsiro), a new generation DES, shows a performance similar to last generation DES and very low LLL if compared with everolimus-eluting stents in general population. We aimed to evaluate global performance in high-risk subgroups: diabetics, AMI and small vessels
MoreTranslated text
Key words
eighteen-month,high-risk,ultrathin-strut,biodegradable-polymer,bioflow-iii
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined